Global Clinical Trial Supply & Logistics Market - 2023-2030

Global Clinical Trial Supply & Logistics Market - 2023-2030

Global clinical trial supply & logistics market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.

Clinical trial supply & logistics involves a complex process that ensures the safe and timely delivery of pharmaceuticals, medical devices, and other materials required for clinical trials.

These trials are essential for testing the safety and effectiveness of new drugs and therapies. This multifaceted domain includes activities such as procurement, storage, packaging, labelling, distribution, and management of clinical trial materials while adhering to strict regulatory guidelines and maintaining the integrity of the trial's data. Effective supply and logistics management is crucial to ensure that trial participants receive the correct investigational products in the right amounts and at the right time. This facilitates the smooth progress of clinical research while upholding patient safety and data quality.

Scope

Metrics Details

CAGR YY%

Market Size Available for Years 2021-2030

Market Estimation Forecast Period 2023-2030

Revenue Units Value (US$ Mn)

Segments Covered Service Type, Phase, Area, End-User

Regions Covered North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Largest Region North America

Fastest Growing Region Asia-Pacific

Report Insights Covered Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.

Market Dynamics: Drivers and Restraints

Improving the supply chain for mRNA vaccine delivery in clinical trials is expected to drive the market growth

Since the beginning of the COVID-19 pandemic, pharmaceutical companies have been racing to develop successful vaccines within expedited periods. The rapid spread of the original virus strain and its subsequent variants across the globe highlighted the importance of vaccine technologies that could be quickly deployed for human trials, with efficacy and safety remaining top priorities.

However, as mRNA vaccines take centre stage, the challenges surrounding their formulation and stability are now becoming evident. One of the major obstacles to mRNA vaccine technology is its dependence on cold chain shipping and storage. Vaccines must be shipped and stored at extremely low temperatures. This requires freezers that can handle temperatures of −80°C, which are not available at every clinical trial site. Since vaccines are subject to strict regulatory controls to ensure their safety and efficacy, the cold chain shipping infrastructure must be in place for mRNA vaccines to realize their full potential.

Therefore, logistics companies play an important role in building reliability in healthcare supply chains by providing end-to-end solutions for storage and transportation at specific temperatures from the point of manufacture to the healthcare facilities where they will be used. As a trusted partner in clinical trial and healthcare logistics, FedEx is well-positioned to handle mRNA vaccine shipments around the world. Since 2020, FedEx has supported shipments of COVID-19 vaccines to more than 60 countries and territories worldwide.

Furthermore, there has been a significant increase in the number of clinical trials, especially in the pharmaceutical and biotechnology industries, as well as a rise in global trials. Due to the strict regulatory requirements for handling and distributing clinical trial materials, the complexity of trials, and the growing use of specialized biological and speciality products, advanced supply chain solutions are needed. The COVID-19 pandemic has highlighted the importance of strong supply chain logistics, resulting in a greater emphasis on pandemic preparedness and contingency planning. These factors collectively propel the clinical trial supply and logistics market forward, ensuring the efficient and compliant management of materials crucial for clinical research.

Restraint:

Challenges in the clinical trial supply chain, managing the supply chain for drug development can be difficult due to complex regulatory requirements and varying timelines. This leads to unpredictable demand fluctuations, making it challenging to plan and allocate resources effectively.

Additionally, the globalization of clinical trials increases the need for cross-border transportation and temperature-sensitive handling of investigational products. This can result in potential supply chain disruptions, customs issues, and temperature excursions. Hence, owing to the above factors, the market is expected to hamper over the forecast period.

For more details on this report – Request for Sample

Segment Analysis

The global clinical trial supply & logistics market is segmented based on service type, phase, area, end-user and region.

The storage and distribution from the service type segment accounted for approximately 45.4% of the clinical trial supply & logistics market share

In the clinical trial supply and logistics market, storage and distribution services play a crucial role in ensuring the safe and efficient handling of investigational products from manufacturing facilities to clinical trial sites. These services provide controlled storage environments, including temperature-controlled conditions when necessary, to maintain the integrity of trial materials.

Outsourcing storage and distribution has several benefits, including cost savings, access to specialized infrastructure and expertise, and the ability to adapt to changing trial demands.

The market for clinical trial services is on the rise due to the increasing complexity and global nature of these trials. There is also a growing need for secure and compliant storage, as well as temperature-sensitive handling, and product launches by the key market players.

For instance, on October 5, 2022, SanaClis, a leading global Clinical Research Organization (CRO), launched its state-of-the-art Clinical Trial Supply Chain Depot. This innovative facility aims to revolutionize the clinical trial industry by centralizing and streamlining the entire supply chain process. It offers a comprehensive range of services, all in one convenient location. By establishing this facility, SanaClis aims to enhance operational efficiency, eliminate delays, and ensure seamless coordination across all stages of the clinical trial process.

Additionally, on May 26, 2023, Catalent is a company that aids in the development and supply of enhanced treatments for patients globally. Recently, the company has expanded its services and capabilities at its facility located in Shiga, Japan. The expansion primarily focuses on the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials.

Prominent companies in this space include Marken, Fisher Clinical Services, Catalent, and World Courier. They offer comprehensive solutions for storage, distribution, and logistics that are tailored to the specific needs of clinical trials. These companies ensure the timely and secure delivery of trial materials to research sites all over the world. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America accounted for approximately 45.6% of the market share in 2022

North America is expected to hold the largest market share, owing to the increasing number of clinical trials, technological advancement in the clinical trial supply & logistics, and product launches by the market players.

For instance, on January 24, 2023, Catalent, a leading company that enables the development and supply of better treatments for patients worldwide, launched a new Case Management Service. This service has been specifically designed to overcome the unique challenges that arise with the safe and timely delivery of advanced therapies to patients. It provides professional supply chain oversight from the beginning to the end of the program to ensure that the logistics of advanced therapy medicinal products (ATMPs), such as cell and gene therapies, are managed efficiently and transported correctly.

Furthermore, 3D printing can aid in the speedy development and iteration of medical devices, which allows for the creation of more effective and personalized solutions. This technology empowers researchers to quickly improve their products based on feedback from clinical trials, leading to more groundbreaking and impactful therapies. Hence, owing to the above factors, the North America region is expected to hold the largest market share over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the clinical trial supply and logistics market. The COVID-19 pandemic has driven the adoption of digital tools and technologies, leading to greater efficiency and reduced costs in the management of clinical trial supply and logistics. The urgent need to develop and distribute vaccines and treatments for COVID-19 has resulted in enhanced collaboration among industry participants, resulting in improved supply chain management and logistics. Regulatory agencies have implemented faster review and approval processes for COVID-19-related clinical trials, leading to quicker supply chain planning and logistics.

In contrast, the global supply chain has been disrupted by lockdowns, travel restrictions, and a surge in demand for medical supplies. As a result, there are shortages of ancillary supplies for clinical trials. The distribution of COVID-19 vaccines and treatments has created challenges in maintaining temperature control, particularly for cold chain logistics. This has led to possible delays and wastage.

The clinical trial ancillary supplies industry is under additional pressure due to the globalization of clinical trials and increased demand caused by COVID-19. This could result in supply shortages and potential delays.

For instance, the United States has a high dependency on China for supplies, which puts the nation at great risk of supply shortages due to ongoing tensions and disruptions to inspections of supply firms in China. To address this issue, the U.S. government is working to finalize an executive order that would provide long-term incentives for U.S.-based companies to produce medications and medical supplies domestically within the U.S.

Furthermore, the COVID-19 pandemic's rapid evolution has caused uncertainty in clinical trial planning and forecasting, making supply and distribution challenging to ensure. Although the initial impact was predominantly negative, the industry has adapted and learned valuable lessons. This could lead to long-term improvements in the clinical trial supply and logistics market.

Market Segmentation:

By Service Type
• Manufacturing
• Packaging and Labeling
• Storage and Distribution
• Comparator Sourcing
• Others

By Phase
• Phase I
• Phase II
• Phase III
• Phase IV

By Area
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Oncology
• Others

By End-User
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Research Institutes and Academic Medical Centers
• Medical Device Companies
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the clinical trial supply & logistics market include Parexel International (MA) Corporation, Catalent, Inc., Marken, Piramal Pharma Solutions, United Parcel Service of America, Inc., FedEx, Movianto, Packaging Coordinators Inc., Biocair, and ICON plc among others.

Key Development
• On April 11, 2022, FedEx Express, a globally renowned express transportation company and a subsidiary of FedEx Corp., was honoured with two awards at the annual IMAPAC Asia Pacific Bioprocessing Excellence Awards 2022. The company was recognized as the ""Best Clinical Trial Logistics Provider"" and for providing the ""Best Last Mile Implementation.""
• On December 1, 2022, Catalent, a global leader in facilitating the development, launch, and supply of better treatments for patients across multiple modalities, announced the completion of its expansion of the clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) located in Shanghai, China. The facility focuses on enabling biopharma, cell, gene, and consumer health partners to optimize their processes.
• On May 26, 2023, Catalent is a company that aims to improve patients' treatments globally by facilitating their development and supply. The company expanded its services and capabilities at its Shiga facility in Japan. The expansion includes the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials.
• On July 07, 2021, Parexel is a prominent global clinical research organization (CRO) that strives to develop and deliver innovative new therapies to advance world health. To ensure timely access to supplies and medications for clinical sites and patients, Parexel is opening a new clinical trial supplies depot in China. China is a major growth market for clinical trials and Parexel.

Why Purchase the Report?
• To visualize the global clinical trial supply & logistics market segmentation based on service type, phase, area, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of clinical trial supply & logistics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global clinical trial supply & logistics market report would provide approximately 69 tables, 74 figures, and 189 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies